This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03579654
Recruitment Status : Unknown
Verified March 2019 by OncBioMune Pharmaceuticals.
Recruitment status was:  Not yet recruiting
First Posted : July 6, 2018
Last Update Posted : March 6, 2019
Information provided by (Responsible Party):
OncBioMune Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 28, 2021
Estimated Study Completion Date : June 30, 2022